Science Explorer Interactive view Map
Company · Montreal · Canada

BioPhage Pharma (Canada)

biophagepharma.net/index.php/enROR OpenAlex
World rank, all time
#23,097
of 42,892
Rank in Canada
#492
of 896
Research works
202
▼ 39% vs 2013–17
Citations
4.5k
22.3 per fractional work
Top-10% rate
9.6%
record average 16.5%
Open access
17%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.20× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 24.25× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.82× its world share, 0 worksChemistryEnvironmental Science: 0.26× its world share, 0 worksEnvironmental ScienceHealth Professions: 2.92× its world share, 0 worksHealth ProfessionsMedicine: 3.89× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 24.2×. Every wedge is a field page.

Which keywords describe research at BioPhage Pharma (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Drug Discovery, Synthesis, Antiretroviral Therapy, Biological Evaluation, Medicinal Chemistry, Adverse Effects, HIV Infection and Drug Resistance.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Drug Discovery20▲ 24×9 topics
  2. Synthesis18▲ 15×13 topics
  3. Antiretroviral Therapy13▲ 28×5 topics
  4. Epidemiology12▲ 1.54×28 topics
  5. Inflammation11▲ 2.3×29 topics
  6. Biological Evaluation11▲ 43×5 topics
  7. Medicinal Chemistry11▲ 14×9 topics
  8. Adverse Effects9▲ 56×2 topics
  9. HIV Infection9▲ 36×2 topics
  10. Drug Resistance9▲ 14×2 topics
  11. Integrase Inhibitors9▲ 103×1 topic
  12. Nucleoside Analogues9▲ 103×1 topic
  13. Anticancer Agents8▲ 16×5 topics
  14. Heterocycles8▲ 21×5 topics
  15. Heterocyclic Compounds8▲ 24×4 topics
  16. Immune Response8▲ 6.0×7 topics
  17. Monoclonal Antibodies7▲ 24×3 topics
  18. Molecular Docking7▲ 24×3 topics
  19. Microwave-Assisted Synthesis7▲ 41×3 topics
  20. Foldamers6▲ 40×1 topic
  21. Peptide Synthesis6▲ 40×1 topic
  22. Antimicrobial6▲ 12×4 topics
  23. Anticancer6▲ 16×3 topics
  24. Antimicrobial Activity6▲ 16×4 topics
  25. Antiviral Therapy6▲ 20×3 topics
  26. Pharmacology6▲ 8.9×6 topics
  27. Biosensors6▲ 5.0×6 topics
  28. Glycosylation6▲ 13×3 topics
  29. Green Chemistry6▲ 9.5×7 topics
  30. Therapeutic Targets5▲ 11×5 topics
  31. Oxidation5▲ 12×2 topics
  32. Cell Signaling5▲ 7.0×7 topics
  33. Genetic Variation5▲ 7.6×4 topics
  34. Liver Disease5▲ 17×3 topics
  35. Asymmetric Synthesis5▲ 16×6 topics
  36. Lab-on-a-Chip5▲ 17×4 topics
  37. Scaffold4▲ 23×2 topics
  38. Biopharmaceuticals4▲ 32×2 topics
  39. Immunogenicity4▲ 42×2 topics
  40. Organic Synthesis4▲ 10×6 topics

Which research topics does BioPhage Pharma (Canada) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers, Platelet Disorders and Treatments and Renal cell carcinoma treatment.

Chronic Lymphocytic Leukemia Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksPlatelet Disorders and T…0Platelet Disorders and Treatments: 0 fractional worksRenal cell carcinoma treatment: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksPharmacological Effects of Natural Compounds: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksDiverse Scientific Resea…0Diverse Scientific Research Studies: 0 fractional worksGastrointestinal Tumor Research and Treatment: 0 fractional worksDermatologic Treatments and Research: 0 fractional works
GeneticsOncologyHematologyPulmonary and Respiratory Medicine6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 0 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
  3. 3 Platelet Disorders and Treatments Hematology 0 works
  4. 4 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  5. 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  6. 6 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  7. 7 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  8. 8 Diverse Scientific Research Studies General Health Professions 0 works
  9. 9 Gastrointestinal Tumor Research and Treatment Gastroenterology 0 works
  10. 10 Dermatologic Treatments and Research Dermatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.4%not open82.6%

World: 28% of research is openly available.

with international co-authors14.0%domestic only86.0%

World: 19% is written across borders.

How has BioPhage Pharma (Canada)'s research output changed?

Output in 2018–2022 was 39% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Montreal

All research institutions in Montreal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.